ConductScience.org, home

Paper34367136

The Role of Cytokines in Predicting the Response and Adverse Events Related to Immune Checkpoint Inhibitors.

Wang M and 6 others. Front Immunol, 2021. Cited by 126 papers, by iCite.

Cite this record

ConductScience Library. The Role of Cytokines in Predicting the Response and Adverse Events Related to Immune Checkpoint Inhibitors. Papers, record 34367136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34367136

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Role of Cytokines in Predicting the Response and Adverse Events Related to Immune Checkpoint Inhibitors.
PubMed
Journal
Front Immunol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
126
iCite
Relative citation ratio, by iCite
6.52
iCite
Revised in PubMed
2024-08-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang MMin
2Zhai XXiaoyang
3Li JJi
4Guan JJingyuan
5Xu SShuhui
6Li YYuYing
7Zhu HHui

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BiomarkersMajor topic
CytokinesMajor topic
Immune Checkpoint InhibitorsMajor topic
Animals
Humans

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07249060Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease PatientsBackground

Source ClinicalTrials.gov

Download CSV of trials

References145

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129093678Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis.Front Pharmacol2017https://conductscience.org/library/papers/29093678PubMed
228187290Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.Cell2017https://conductscience.org/library/papers/28187290PubMed
329443960TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.Nature2018https://conductscience.org/library/papers/29443960PubMed
429598848Dual Transforming Growth Factor-β and Programmed Death-1 Blockade: A Strategy for Immune-Excluded Tumors?Trends Immunol2018https://conductscience.org/library/papers/29598848PubMed
534031618Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity.Nat Immunol2021https://conductscience.org/library/papers/34031618PubMed
67566090Induction of apoptosis in mature T cells by tumour necrosis factor.Nature1995https://conductscience.org/library/papers/7566090PubMed
727885276Immunoregulation by members of the TGFβ superfamily.Nat Rev Immunol2016https://conductscience.org/library/papers/27885276PubMed
89636188Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9636188PubMed
926406148Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.N Engl J Med2015https://conductscience.org/library/papers/26406148PubMed
1026380086Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma.J Immunother Cancer2015https://conductscience.org/library/papers/26380086PubMed
1118503261Concurrent decrease in IL-10 with development of immune-related adverse events in a patient treated with anti-CTLA-4 therapy.Cancer Immun2008https://conductscience.org/library/papers/18503261PubMed
1212732663Deficiencies of GM-CSF and interferon gamma link inflammation and cancer.J Exp Med2003https://conductscience.org/library/papers/12732663PubMed
1327157491Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial.Lancet Oncol2016https://conductscience.org/library/papers/27157491PubMed
1427348007The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance.Vaccines (Basel)2016https://conductscience.org/library/papers/27348007PubMed
1530339766The Ratio of Peripheral Regulatory T Cells to Lox-1+ Polymorphonuclear Myeloid-derived Suppressor Cells Predicts the Early Response to Anti-PD-1 Therapy in Patients with Non-Small Cell Lung Cancer.Am J Respir Crit Care Med2019https://conductscience.org/library/papers/30339766PubMed
1631043740Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy.Nature2019https://conductscience.org/library/papers/31043740PubMed
171103152An endotoxin-induced serum factor that causes necrosis of tumors.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/1103152PubMed
1831664934Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: potential role of Th1-dominant immune response in immune-related adverse events: two case reports.BMC Cancer2019https://conductscience.org/library/papers/31664934PubMed
1928939128Early Immune-Related Adverse Events and Association with Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study.J Thorac Oncol2017https://conductscience.org/library/papers/28939128PubMed
2010688256Cytokines and their receptors: an overview.Ther Drug Monit2000https://conductscience.org/library/papers/10688256PubMed

See all 145 referencesDownload CSV of references

Cited by95

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 126 citations.

PMIDTitleJournalYearIn PapersSource
42985639Long non-coding RNA prompts immune-related adverse events risk and immunotherapy response in pan-cancer.iScience2026https://conductscience.org/library/papers/42985639PubMed
42799102A Case Series of Raynaud's Phenomenon in the Setting of Immune Checkpoint Inhibitors.J Immunother Precis Oncol2026https://conductscience.org/library/papers/42799102PubMed
42756887Exposure-response relationship of sintilimab in advanced gastric cancer: insights from time-dependent pharmacokinetics and biomarker integration for precision immunotherapy.Front Pharmacol2026https://conductscience.org/library/papers/42756887PubMed
42732396Severe Immune-Related Adverse Events Associated with Durable Antitumor Responses Following Immune Checkpoint Inhibitor Therapy: Two Case Reports.Cancer Manag Res2026https://conductscience.org/library/papers/42732396PubMed
42582583Baseline IL-6, IL-8, IFN-ω, and perforin as prognostic biomarkers in immune checkpoint inhibitor-treated metastatic non-small cell lung cancer.Transl Lung Cancer Res2026https://conductscience.org/library/papers/42582583PubMed
42501206A baseline systemic inflammatory signature predicts anti-PD-1 response in advanced melanoma.Clin Transl Oncol2026https://conductscience.org/library/papers/42501206PubMed
42344718Long-term survival with tocilizumab treatment for tislelizumab-related pneumonitis in a patient with non-small cell lung cancer: A case report.Oncol Lett2026https://conductscience.org/library/papers/42344718PubMed
42192983In-Treatment Kinetics of Peripheral Blood Immune Markers in PD-L1 High Non-Small Cell Lung Cancer and Prognostic Relevance for Immunotherapy Outcomes.Cancers (Basel)2026https://conductscience.org/library/papers/42192983PubMed
42135662Single-cell and machine learning reveal ROS-associated heterogeneity in hepatocellular carcinoma for precision medicine.BMC Cancer2026https://conductscience.org/library/papers/42135662PubMed
42133231Immunological Drug-Drug Interactions in Immune Checkpoint Inhibitor Therapy: Mechanisms, Clinical Evidence, and Artificial Intelligence.Curr Oncol Rep2026https://conductscience.org/library/papers/42133231PubMed
42118587IL-6 receptor blockade impedes proinflammatory atypical Treg subset associated with immune checkpoint inhibitor-induced inflammatory arthritis.J Clin Invest2026https://conductscience.org/library/papers/42118587PubMed
42093111Peripheral Blood Biomarkers Predict Outcomes in Advanced Cancers Treated With Anti-PD-1 Therapy.Immun Inflamm Dis2026https://conductscience.org/library/papers/42093111PubMed
41992363Cancer in transition: discovery of tumor-intrinsic transcriptional programs shaping the immune and microenvironmental landscape.Biomark Res2026https://conductscience.org/library/papers/41992363PubMed
41836401Immune checkpoint inhibitor therapy for gastric cancer: current status, therapeutic challenges, and future prospects.Front Immunol2026https://conductscience.org/library/papers/41836401PubMed
41775992In-depth Evaluation of the Olink Target 48 Cytokine Panel: Inter-Laboratory Evaluation of Performance and Reliability for Biomarker Studies in Oncology.AAPS J2026https://conductscience.org/library/papers/41775992PubMed
41751379Periodontitis-Induced Immune Reprogramming: Implications for Cancer Immunotherapy Response.Biomedicines2026https://conductscience.org/library/papers/41751379PubMed
41740058Combination Immunotherapy as a Promising Strategy to Overcome Immunotherapy Resistance: From Emergence to Next-Generation Approaches.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41740058PubMed
41727433Impact of immune-related adverse events on treatment outcomes in advanced esophageal squamous cell carcinoma treated with immune checkpoint inhibitors.Front Immunol2026https://conductscience.org/library/papers/41727433PubMed
41591497Metabolic syndrome and immune-related adverse events.Cancer Immunol Immunother2026https://conductscience.org/library/papers/41591497PubMed
41470133Sleep Quality and Its Determinants Among Patients with Metastatic Cancer Treated with Immune Checkpoint Inhibitors: A Two-Center Cross-Sectional Study.Medicina (Kaunas)2025https://conductscience.org/library/papers/41470133PubMed

See all 95 cited byDownload CSV of cited by

Genes58

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BMP1649PubTator's text mininghttps://conductscience.org/library/genes/649NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
COPS510987PubTator's text mininghttps://conductscience.org/library/genes/10987NCBI Gene
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401NCBI Gene
CSF21437PubTator's text mininghttps://conductscience.org/library/genes/1437NCBI Gene
CSF31440PubTator's text mininghttps://conductscience.org/library/genes/1440NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
CX3CL16376PubTator's text mininghttps://conductscience.org/library/genes/6376NCBI Gene
CXCL103627PubTator's text mininghttps://conductscience.org/library/genes/3627NCBI Gene
CXCL116373PubTator's text mininghttps://conductscience.org/library/genes/6373NCBI Gene
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
CXCL94283PubTator's text mininghttps://conductscience.org/library/genes/4283NCBI Gene
CXCR13577PubTator's text mininghttps://conductscience.org/library/genes/3577NCBI Gene
CXCR23579PubTator's text mininghttps://conductscience.org/library/genes/3579NCBI Gene
EGF1950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
FADD8772PubTator's text mininghttps://conductscience.org/library/genes/8772NCBI Gene
FAS355PubTator's text mininghttps://conductscience.org/library/genes/355NCBI Gene
FGF22247PubTator's text mininghttps://conductscience.org/library/genes/2247NCBI Gene

See all 58 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34367136

GET https://conductscience.org/api/papers/v1/34367136/references?page=2